Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.20
Bid: 44.10
Ask: 45.90
Change: -0.50 (-1.10%)
Spread: 1.80 (4.082%)
Open: 43.00
High: 43.20
Low: 43.00
Prev. Close: 45.50
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Land-based Broodstock Facility Reaches Milestone

30 Oct 2017 07:00

RNS Number : 9021U
Benchmark Holdings PLC
30 October 2017
 

Benchmark Holdings plc("Benchmark" or the "Company")

 

Construction of land-based salmon broodstock facility reaches significant milestone

 

Benchmark today announces that its new land-based salmon broodstock facility in Norway is now ready to house its first batch of broodstock. The 10,000 square-meter facility will receive delivery of the first stock in November from Salten, the joint venture partner of Benchmark's subsidiary SalmoBreed, who have been growing SalmoBreed's genetic material. Salmon eggs from this stock will be produced early Autumn 2018 and first test batch sales are expected two months later.

 

The new facility will deliver eggs throughout the year for the entire production cycle and will be the first of its kind to do so in Norway. Smolt (young salmon) from SalmoBreed's breeding station in Lønningdal will also be delivered in November. This new site, which is based on Benchmark's Icelandic model, is fully-biosecure and has the capacity to produce over 150 million ova per year.

 

The build of the facility is on schedule and is expected to reach full capacity by Autumn 2019.

 

Malcolm Pye, Benchmark CEO, commented:

"SalmoBreed Salten will be the world's most advanced facility. This additional capacity will allow us to take up our production to meet the increasing demand for disease free, year-round salmon ova and support the strong growth of the Norwegian salmon industry.

 

"Norway is a leading player in salmon and there is a continuous drive towards improvements in production efficiency traits, disease resistance and product quality . Benchmark are well-placed to address this through our robust breeding programmes that are proven to tackle some of the industry's biggest challenges."

 

 

-ENDS-

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

Tavistock

Tel: 020 7920 3150

Sophie Praill / Simon Hudson

 

Notes to Editors:

Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.

 

Since 2000, Benchmark has consistently worked to build a platform to serve its customers, helping farmers to take control of their biological environment through the combination of genetics, nutrition, health and knowledge services. Through its in-depth knowledge of animal biology, Benchmark is able to tackle the key issues in the aquaculture, livestock and companion animal sectors.

 

The Company has proven distribution capabilities in high growth markets and operates internationally with R&D facilities, commercial farms, diagnostic laboratories, manufacturing sites, production facilities and commercial offices across 27 countries in five continents. As at 30 September 2017, Benchmark employed 952 people. 

 

For further information on Benchmark please visit www.benchmarkplc.com 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABIBDGXDDBGRC
Date   Source Headline
11th Oct 201911:15 amRNSDIRECTOR DEALINGS
30th Sep 20197:00 amRNSTotal Voting Rights
27th Sep 20197:00 amRNSDIRECTOR DEALINGS
20th Sep 20197:00 amRNSBlock listing Interim Review
17th Sep 20197:00 amRNSHolding(s) in Company
16th Sep 20197:00 amRNSDIRECTOR DEALINGS
16th Sep 20197:00 amRNSDIRECTOR DEALINGS
12th Sep 20194:25 pmRNSHolding(s) in Company
12th Sep 201911:15 amRNSHolding(s) in Company
11th Sep 20197:00 amRNSUpdate on commercial licensing deals
30th Aug 20197:00 amRNSTotal Voting Rights
19th Aug 20197:00 amRNSDirectorate Change
16th Aug 20193:55 pmRNSDetails of Investor Call
14th Aug 20197:00 amRNSDirectorate Change
12th Aug 20197:00 amRNSQ3 Trading Update
31st Jul 20191:15 pmRNSReplacement: Total Voting Rights
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 20197:00 amRNSGenetics Breakthrough in Tilapia
9th Jul 20197:00 amRNSDirectorate Change
2nd Jul 20193:49 pmRNSHolding(s) in Company
2nd Jul 20197:00 amRNSHolding(s) in Company
28th Jun 20194:41 pmRNSSecond Price Monitoring Extn
28th Jun 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20192:05 pmRNSSecond Price Monitoring Extn
28th Jun 20192:00 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSTotal Voting Rights
25th Jun 20197:00 amRNSInterim Results
13th Jun 20198:00 amRNSPlacement of a new senior secured bond issue
10th Jun 20197:00 amRNSUpdate on Joint Venture with AquaChile
3rd Jun 20197:00 amRNSTrading Update and Investor Meetings
31st May 20197:00 amRNSTotal Voting Rights
29th May 20197:00 amRNSUpdate on Joint Venture with AquaChile
30th Apr 20197:00 amRNSTotal Voting Rights
29th Mar 20192:25 pmRNSReplacement: Total Voting Rights
29th Mar 20197:00 amRNSTotal Voting Rights
21st Mar 20197:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Mar 201912:21 pmRNSResult of AGM
28th Feb 20197:00 amRNSTotal Voting Rights
20th Feb 20197:00 amRNSAppointment of Non-Executive Director
29th Jan 20193:07 pmRNSPosting of Annual Report & Notice of AGM
28th Jan 20198:00 amRNSDIRECTOR SHARE OPTIONS
24th Jan 20197:00 amRNSFull Year Results
14th Jan 20197:00 amRNSNotice of Results
31st Dec 20188:00 amRNSTotal Voting Rights
12th Dec 20183:08 pmRNSDirector/PDMR Shareholding
12th Dec 201811:01 amRNSHolding(s) in Company
10th Dec 20185:05 pmRNSHolding(s) in Company
7th Dec 20183:35 pmRNSHolding(s) in Company
30th Nov 20187:00 amRNSTotal Voting Rights
30th Nov 20187:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.